- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02426970
Are Acceptance and Commitment Related to Treatment Response in Chronic Low Back Pain (COP-PAIN)
Studieoversikt
Status
Forhold
Detaljert beskrivelse
The secondary objectives are:
A. To search for correlations between the acceptance score (AAQ-II Questionnaire) and scores for coping (CSQ), avoidance (FABQ), understanding (BBQ), anxiety and depression (HADS) and quality of life (SF-12) at baseline.
B. To describe the kinetics of changes in various parameters (acceptance, coping, avoidance, understanding, anxiety and depression, quality of life, ODI) over 6 months.
C. To evaluate the agreement between two methods of questionnaire presentation: Paper collection versus collection by Tablet PC.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Montpellier, Frankrike, 34295
- CHRU de Montpellier - Hôpital Lapeyronie
-
Nîmes Cedex 09, Frankrike, 30029
- CHRU de Nîmes - Hôpital Universitaire Carémeau
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- The patient has been informed about the study, and is not opposed to the study
- The patient must be insured or beneficiary of a health insurance plan
- The patient is available for 6 month of follow-up
- The subject has chronic back pain that is not post-operative in nature and that has lasted for more than 3 months
- The subject accepts the re-education curriculum.
Exclusion Criteria:
- The patient is participating in another study
- The patient is in an exclusion period determined by a previous study
- The patient is under judicial protection, under tutorship or curatorship
- The patient refuses to participate
- It is impossible to correctly inform the patient
- The patient is pregnant, parturient, or breastfeeding
- The subject has a history of chronic obstructive pulmonary disease, cardiovascular disease, rheumatoid arthritis, lupus, spondylitis or neoplastic disease.
- Patient currently under psychological treatment
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
---|
Lumbar spine pain inpatients
The study population corresponds to inpatient rehabilitative care for lumbar spine pain in the Departments of Physical Medicine and Functional Rehabilitation at the Nîmes and Montpellier University Hospitals.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Classification of the patient as a responder or a non responder
Tidsramme: 6 months
|
The response to treatment will be evaluated by the ODI (Oswestry Disability Index) at 6 months: a patient will be considered as a responder when the absolute change between the score at 6 months and inclusion is at least 10 points (Ostelo RW et al., 2008). This outcome is a qualitative variable with two options: responder or non-responder. The fact that we define in an apriori fashion who is a responder or not does not mean that we have created multiple outcomes. This is a single outcome. |
6 months
|
Acceptation and Action Questionnaire - II (AAQ-II) score
Tidsramme: Day -7 (inclusion)
|
Day -7 (inclusion)
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
the AAQ-II Score
Tidsramme: Day 0
|
Day 0
|
the AAQ-II Score
Tidsramme: Month 1
|
Month 1
|
the AAQ-II Score
Tidsramme: Month 3
|
Month 3
|
the AAQ-II Score
Tidsramme: Month 6
|
Month 6
|
Oswestry Disability Index
Tidsramme: Day -7
|
Day -7
|
Oswestry Disability Index
Tidsramme: Day 0
|
Day 0
|
Oswestry Disability Index
Tidsramme: Month 1
|
Month 1
|
Oswestry Disability Index
Tidsramme: Month 3
|
Month 3
|
Oswestry Disability Index
Tidsramme: Month 6
|
Month 6
|
Coping Strategies Questionnaire in French (CSQ-F)
Tidsramme: Day -7
|
Day -7
|
Coping Strategies Questionnaire in French (CSQ-F)
Tidsramme: Day 0
|
Day 0
|
Coping Strategies Questionnaire in French (CSQ-F)
Tidsramme: Month 1
|
Month 1
|
Coping Strategies Questionnaire in French (CSQ-F)
Tidsramme: Month 3
|
Month 3
|
Coping Strategies Questionnaire in French (CSQ-F)
Tidsramme: Month 6
|
Month 6
|
The Back Beliefs Questionnaire
Tidsramme: Day -7
|
Day -7
|
The Back Beliefs Questionnaire
Tidsramme: Day 0
|
Day 0
|
The Back Beliefs Questionnaire
Tidsramme: Month 1
|
Month 1
|
The Back Beliefs Questionnaire
Tidsramme: Month 3
|
Month 3
|
The Back Beliefs Questionnaire
Tidsramme: Month 6
|
Month 6
|
The Fear-Avoidance Beliefs Questionnaire
Tidsramme: Day -7
|
Day -7
|
The Fear-Avoidance Beliefs Questionnaire
Tidsramme: Day 0
|
Day 0
|
The Fear-Avoidance Beliefs Questionnaire
Tidsramme: Month 1
|
Month 1
|
The Fear-Avoidance Beliefs Questionnaire
Tidsramme: Month 3
|
Month 3
|
The Fear-Avoidance Beliefs Questionnaire
Tidsramme: Month 6
|
Month 6
|
The Hospital Anxiety and Depression Scale
Tidsramme: Day -7
|
Day -7
|
The Hospital Anxiety and Depression Scale
Tidsramme: Day -0
|
Day -0
|
The Hospital Anxiety and Depression Scale
Tidsramme: Month 1
|
Month 1
|
The Hospital Anxiety and Depression Scale
Tidsramme: Month 3
|
Month 3
|
The Hospital Anxiety and Depression Scale
Tidsramme: Month 6
|
Month 6
|
The SF-12 questionnaire
Tidsramme: Day -7
|
Day -7
|
The SF-12 questionnaire
Tidsramme: Day 0
|
Day 0
|
The SF-12 questionnaire
Tidsramme: Month 1
|
Month 1
|
The SF-12 questionnaire
Tidsramme: Month 3
|
Month 3
|
The SF-12 questionnaire
Tidsramme: Month 6
|
Month 6
|
Average pain over the last 8 days measured via visual analog scale.
Tidsramme: Day -7
|
Day -7
|
Average pain over the last 8 days measured via visual analog scale.
Tidsramme: Day 0
|
Day 0
|
Average pain over the last 8 days measured via visual analog scale.
Tidsramme: Month 1
|
Month 1
|
Average pain over the last 8 days measured via visual analog scale.
Tidsramme: Month 3
|
Month 3
|
Average pain over the last 8 days measured via visual analog scale.
Tidsramme: Month 6
|
Month 6
|
Maximum pain over the last 8 days measured via visual analog scale.
Tidsramme: Day -7
|
Day -7
|
Maximum pain over the last 8 days measured via visual analog scale.
Tidsramme: Day 0
|
Day 0
|
Maximum pain over the last 8 days measured via visual analog scale.
Tidsramme: Month 1
|
Month 1
|
Maximum pain over the last 8 days measured via visual analog scale.
Tidsramme: Month 3
|
Month 3
|
Maximum pain over the last 8 days measured via visual analog scale.
Tidsramme: Month 6
|
Month 6
|
Samarbeidspartnere og etterforskere
Etterforskere
- Studieleder: Arnaud Dupeyron, MD, PhD, Centre Hospitalier Universitaire De Nimes
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- AOI/2014/AD-01
- 2014-A01373-44 (Annen identifikator: RCB number)
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Smerte i korsryggen
-
Bozok UniversityFullført
-
Otsuka Pharmaceutical Co., Ltd.Aktiv, ikke rekrutterendeHyper-low-density Lipoprotein (LDL) KolesterolemiJapan
-
Health Services Academy, Islamabad, PakistanUkjentmHelse | Gjeninnleggelse | Teach-back kommunikasjonPakistan
-
Rush University Medical CenterFullførtPasientutdanning | Teach-back kommunikasjon | Etter besøksinstruksjoner | PasientforståelseForente stater
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, WisconsinAktiv, ikke rekrutterendeSimulering av fysisk sykdom | Trakeostomikomplikasjon | Teach-back kommunikasjonForente stater
-
Otsuka Pharmaceutical Co., Ltd.FullførtHyper-low-density Lipoprotein (LDL) KolesterolemiJapan
-
Marmara UniversityAktiv, ikke rekrutterendeTeach-back kommunikasjonTyrkia
-
Jordan Collaborating Cardiology GroupThe Cardiovascular Academy Group of the JCS; The Jordan Cardiac Society... og andre samarbeidspartnereAvsluttetAterosklerotisk kardiovaskulær risiko | Low-density-lipoprotein (LDL) kolesterolJordan
-
University of ValenciaFullført
-
Nina HermansUniversity Hospital, AntwerpRekrutteringLow-density-lipoprotein-type [LDL] HyperlipoproteinemiBelgia